Pharmaceutical Online Videos
-
The Key To HPAPI Manufactuting Success
3/1/2024
Watch to explore a training center dedicated to the development and manufacturing of HPAPIs that is setting a new industry standard for safety and expertise.
-
Novartis Contract Manufacturing Capacity Update February 2024: Large Molecule
2/28/2024
As we expand our mammalian capacity across the manufacturing network, updates on completion dates and capacity availability are presented in the session.
-
Abzena Capacity Update February 2024: Large Molecule
2/28/2024
Hear expert insight from Abzena’s CTO on how to de-risk and streamline the development of your biopharmaceutical in order to successfully meet your next regulatory or clinical milestone.
-
Simtra BioPharma Solutions Capacity Update February 2024: Large Molecule
2/28/2024
Simtra currently has open capacity for liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project and the availability of materials.
-
Aldevron Capacity Update February 2024: Cell & Gene
2/28/2024
Examine Aldevron's custom manufacturing services and ready-for-use products to support your pipeline and review our new capacity for cGMP RNP manufacturing to streamline CRISPR gene editing programs.
-
Nanoform Capacity Update February 2024: Small Molecule
2/28/2024
Discover Nanoform’s manufacturing capabilities, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients.
-
Novartis Contract Manufacturing Capacity Update February 2024: Cell & Gene
2/28/2024
Gain an overview of the CGT manufacturing services provided by Novartis Contract Manufacturing and how the in-house capabilities within our network can support clients' needs in end-to-end production.
-
EirGenix Inc. Capacity Update February 2024: Large Molecule
2/28/2024
EirGenix has immediate availability of capacity up to 12 x 2,000 L SUBs for mammalian cells and up to 150 L scale for microbial and that will increase to 350L and 1,000L by end of this year.
-
Resilience US, Inc. Capacity Update February 2024: Large Molecule
2/28/2024
With a strong network of sites, Resilience provides innovative solutions and services for established and emerging therapies. Learn how we can support your development and manufacturing programs.
-
Singota Solutions Capacity Update February 2024: Large Molecule
2/28/2024
In this presentation from the February 2024 OPCU event, discover Singota’s capabilities in providing formulation development, analytical development, aseptic manufacturing, and supply chain services.